Published in Infect Immun on August 01, 2001
Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol (2004) 1.54
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J (2001) 1.40
Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog (2017) 1.38
Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am J Respir Crit Care Med (2005) 1.33
Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun (2004) 1.25
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator. Infect Immun (2010) 1.18
In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol (2002) 1.16
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxia-inducible factor-1alpha. Crit Care (2002) 1.07
Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun (2002) 1.07
Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res (2010) 1.03
Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc Natl Acad Sci U S A (2003) 0.97
Burkholderia cenocepacia ET12 strain activates TNFR1 signalling in cystic fibrosis airway epithelial cells. Cell Microbiol (2007) 0.97
Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice. Inflamm Res (2009) 0.96
Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice. Infect Immun (2010) 0.89
Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS One (2010) 0.88
Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-kappaB. Crit Care (2002) 0.86
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
Abnormal expression of Muc5b in Cftr-null mice and in mammary tumors of MMTV-ras mice. Histochem Cell Biol (2011) 0.80
FAB-MS characterization of sialyl Lewis x determinants on polylactosamine chains of human airway mucins secreted by patients suffering from cystic fibrosis or chronic bronchitis. Glycoconj J (2001) 0.80
Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia. Appl Environ Microbiol (2009) 0.79
Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference. Cell Res (2005) 0.78
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences. Biomed Res Int (2016) 0.76
Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator. Respir Res (2006) 0.76
Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance. Front Microbiol (2015) 0.75
Burkholderia cepacia Complex Vaccines: Where Do We Go from here? Vaccines (Basel) (2016) 0.75
HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infect Immun (2017) 0.75
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem (1991) 8.81
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 6.84
Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell (1998) 6.72
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol (1993) 5.16
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science (1996) 3.38
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol (1997) 3.33
Role of CFTR in airway disease. Physiol Rev (1999) 3.33
Burkholderia cepacia. Management issues and new insights. Clin Chest Med (1998) 3.23
Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest (1993) 3.00
Innate immunity and pulmonary host defense. Immunol Rev (2000) 2.48
Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem (1995) 2.44
Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax (1998) 2.20
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest (1997) 2.10
Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol (1999) 1.93
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun (1998) 1.80
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol (2000) 1.56
Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology (1999) 1.51
Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax (1998) 1.50
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest (1989) 1.46
Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol (1994) 1.39
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet (1995) 1.37
Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med (1995) 1.36
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun (1999) 1.34
Cystic fibrosis and the salt controversy. Cell (1999) 1.31
Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax (1996) 1.29
Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol (2000) 1.28
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin. J Biol Chem (1994) 1.17
Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun (1999) 1.17
Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res (1996) 1.16
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun (1997) 1.11
The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol (1998) 1.09
Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J Clin Microbiol (2000) 1.07
Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. Am J Respir Crit Care Med (1998) 1.04
Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo. J Immunol (2000) 1.01
A murine model of cystic fibrosis. Am J Respir Crit Care Med (1995) 1.00
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect Immun (1999) 1.00
Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol (1997) 1.00
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia. J Infect Dis (2000) 1.00
Cyclic AMP signaling pathways are important in IL-1 beta transcriptional regulation. J Immunol (1995) 0.98
Efficient killing of inhaled bacteria in DeltaF508 mice: role of airway surface liquid composition. Am J Physiol (1999) 0.96
Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis. Mod Pathol (2000) 0.94
Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein. Am J Med (1998) 0.85
Bacteremic community-acquired pneumonia in an immunocompetent adult due to Burkholderia cepacia. Chest (1999) 0.81
Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia. Aust N Z J Med (2000) 0.80
Treatment of airway inflammation in cystic fibrosis. Curr Opin Pulm Med (1996) 0.78
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 6.70
Cryptochromes: blue light receptors for plants and animals. Science (1999) 4.29
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 4.17
Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients? BMJ (1996) 3.58
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science (1989) 3.12
Stoma closure and wound infection: an evaluation of risk factors. Can J Surg (1995) 3.02
Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death. Am J Transplant (2013) 2.88
Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci (1997) 2.88
A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell (1981) 2.87
Humans and great apes share a large frontal cortex. Nat Neurosci (2002) 2.75
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
The C termini of Arabidopsis cryptochromes mediate a constitutive light response. Cell (2000) 2.53
Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol (2001) 2.44
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol (2000) 2.43
A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res (1994) 2.35
Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet (1996) 2.32
Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood (2000) 2.26
An SH3 binding region in the epithelial Na+ channel (alpha rENaC) mediates its localization at the apical membrane. EMBO J (1994) 2.10
Neutrophil activation and acute lung injury. Curr Opin Crit Care (2001) 2.09
Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A (1976) 2.02
Can we prevent accidental injury to adolescents? A systematic review of the evidence. Inj Prev (1995) 1.96
Phagosomal acidification is mediated by a vacuolar-type H(+)-ATPase in murine macrophages. J Biol Chem (1990) 1.94
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol (1999) 1.93
The role of actin-binding protein 280 in integrin-dependent mechanoprotection. J Biol Chem (1998) 1.89
Liver damage in heatstroke. Am J Med (1970) 1.81
Surgical complications of Tenckhoff catheters used in continuous ambulatory peritoneal dialysis. Singapore Med J (2006) 1.80
Antimicrobial prophylaxis in surgery. Committee on Antimicrobial Agents, Canadian Infectious Disease Society. CMAJ (1994) 1.79
Autophagic vacuoles in human red cells. Am J Pathol (1966) 1.76
Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. Blood (1998) 1.74
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med (1998) 1.73
Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab Invest (1988) 1.72
Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med (2001) 1.72
A pH-sensitive and voltage-dependent proton conductance in the plasma membrane of macrophages. J Gen Physiol (1993) 1.71
Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protects rats against sepsis. Crit Care Med (1994) 1.71
Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J Exp Med (1997) 1.71
Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project. Am J Epidemiol (1996) 1.68
Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab (2000) 1.67
NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut (2007) 1.66
Human intestinal goblet cell mucin. Can J Biochem (1976) 1.65
Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol (1998) 1.62
Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg (1997) 1.60
Measurement of total blood flow in the normal human retina using Doppler Fourier-domain optical coherence tomography. Br J Ophthalmol (2009) 1.56
The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology (2003) 1.55
Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ "leak". J Biol Chem (1991) 1.54
Regulation of phagosomal acidification. Differential targeting of Na+/H+ exchangers, Na+/K+-ATPases, and vacuolar-type H+-atpases. J Biol Chem (1997) 1.52
Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51
v-SNARE-dependent secretion is required for phagocytosis. Proc Natl Acad Sci U S A (1998) 1.47
Morphologic variants of alcoholic hyalin. Am J Pathol (1972) 1.45
Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.44
Lung disease in mice with cystic fibrosis. J Clin Invest (1997) 1.44
A vacuolar type H(+)-ATPase regulates cytoplasmic pH in murine macrophages. J Biol Chem (1990) 1.42
Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41
Intestinal goblet cell mucus: isolation and identification by immunofluorescence of a goblet cell glycoprotein. J Cell Sci (1973) 1.41
P450/losec. Gastroenterology (1991) 1.40
Adjusting to disfigurement: processes involved in dealing with being visibly different. Clin Psychol Rev (2001) 1.40
Cancer associated human papillomavirus perinatal transmission and persistence. Br J Obstet Gynaecol (1995) 1.39
Topical tacrolimus in the management of lichen sclerosus. BJOG (2006) 1.39
The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem (1992) 1.38
Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol (1998) 1.36
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med (1994) 1.34
Mechanisms of lipopolysaccharide-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties. J Immunol (1992) 1.34
Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am J Physiol Gastrointest Liver Physiol (2001) 1.33
Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Natl Acad Sci U S A (2001) 1.33
Cell volume-dependent phosphorylation of proteins of the cortical cytoskeleton and cell-cell contact sites. The role of Fyn and FER kinases. J Biol Chem (2000) 1.31
Neutral and acidic species of human intestinal mucin. Evidence for different core peptides. J Biol Chem (1985) 1.31
The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. J Clin Invest (1992) 1.28
Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol (2000) 1.28
Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol (1997) 1.25
Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24
Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes (1995) 1.24
Signaling functions of L-selectin. Enhancement of tyrosine phosphorylation and activation of MAP kinase. J Biol Chem (1995) 1.24
Mechanism of decreased in vitro murine macrophage cytokine release after exposure to carbon dioxide: relevance to laparoscopic surgery. Ann Surg (1997) 1.24
Regulation of neutrophil activation in acute lung injury. Chest (1999) 1.23
Typhlitis. Can J Surg (1999) 1.22
Focal localization of the NHE-1 isoform of the Na+/H+ antiport: assessment of effects on intracellular pH. EMBO J (1993) 1.22
Comparison of temporal filtering methods for dynamic contrast MRI myocardial perfusion studies. Magn Reson Med (2003) 1.20
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol (2001) 1.19
Intracellular pH regulation during spreading of human neutrophils. J Cell Biol (1996) 1.19
A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med (1992) 1.18
Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol (2000) 1.18
Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin. J Biol Chem (1994) 1.17
Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci U S A (1994) 1.17
Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res (1996) 1.16
Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med (1985) 1.16
Regulation of cytoplasmic pH in osteoclasts. Contribution of proton pumps and a proton-selective conductance. J Biol Chem (1995) 1.15
The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J Immunol (1998) 1.15
Characterization and subcellular localization of target membrane soluble NSF attachment protein receptors (t-SNAREs) in macrophages. Syntaxins 2, 3, and 4 are present on phagosomal membranes. J Immunol (1996) 1.15
Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin (2001) 1.15
Clinical aspects of gastrointestinal mucus. Adv Exp Med Biol (1982) 1.13
Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.13
Actin filaments facilitate insulin activation of the src and collagen homologous/mitogen-activated protein kinase pathway leading to DNA synthesis and c-fos expression. J Biol Chem (1998) 1.13
The Bacteroides by-product succinic acid inhibits neutrophil respiratory burst by reducing intracellular pH. Infect Immun (1987) 1.13
A novel model system for characterization of phagosomal maturation, acidification, and intracellular collagen degradation in fibroblasts. J Biol Chem (2000) 1.11